Consequently, A20 leads to an inhibition of caspase 8 activation and subsequently to resistance to TRAIL-induced apoptosis in glioblastoma or hepatocellular carcinoma cells [35, 36]. The gene discussed is CASP8; the disease is glioblastoma.